Close Menu

NEW YORK – Tempus said Friday that it has closed a $100 million Series G round of funding, bringing the company's total capital raised since its founding in 2015 to $620 million and its valuation to $5 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

In Science this week: chromatin accessibility of microglia during fetal development, and more.